Drug eluting stents versus bare metal stents for the treatment of saphenous vein grafts failure: learnings from the DIVA trial

We read with great interest the DIVA (Drug eluting stent versus bare metal stent in saphenous vein graft angioplasty) trial by Brilakis and colleagues (1) that was designed to answer a remaining controversial question on the choice of the optimal stent type for the treatment of saphenous vein grafts (SVG) failure.